Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Deep-Well Microplates

By Drug Discovery Trends Editor | August 15, 2012

Deep-well polypropylene microplates from Porvair Sciences are shown in a new applications report to contain almost no significant levels of leachable or extractable compounds which might affect the integrity of stored samples.

The report shows the result of GC/MS analysis carried out by Porvair Sciences on a wide range of different manufacturers’ polypropylene deep well plates to establish levels of extractable or leachable contaminants in each of them.  While the Porvair plates showed no significant contaminants many of the deep well plates from alternative sources showed  contaminating peaks from chemicals used in the polypropylene to assist the injection moulding process.

Manufactured under class 10,000 conditions from ultra-pure grade polypropylene, Porvair deep well plates contain no contaminants that may leach out and affect stored samples or cell growth.  For sensitive biological applications – Porvair offers a selection of deep well plates that are available certified as RNase / DNase free.  Available in a choice of formats, volumes and well shapes – Porvair deep well plates are precisely manufactured to SBS/ANSI dimensions ensuring complete compatibility with microplate washers and automated equipment.

Porvair Sciences

The report shows the result of GC/MS analysis carried out by Porvair Sciences on a wide range of different manufacturers’ polypropylene deep well plates to establish levels of extractable or leachable contaminants in each of them.  While the Porvair plates showed no significant contaminants many of the deep well plates from alternative sources showed  contaminating peaks from chemicals used in the polypropylene to assist the injection moulding process.

Manufactured under class 10,000 conditions from ultra-pure grade polypropylene, Porvair deep well plates contain no contaminants that may leach out and affect stored samples or cell growth.  For sensitive biological applications – Porvair offers a selection of deep well plates that are available certified as RNase / DNase free.  Available in a choice of formats, volumes and well shapes – Porvair deep well plates are precisely manufactured to SBS/ANSI dimensions ensuring complete compatibility with microplate washers and automated equipment.

Porvair Sciences


Filed Under: Drug Discovery

 

Related Articles Read More >

Pharmacovigilance
A new era of pharmacovigilance: Worldwide master key for drug safety monitoring
Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50